Showing results (61-70 of 268) with videos related to
Sort By:
Pageof 27
Synapse (New York, N.Y.)|June 23, 1998
Inhibition of NMDA-receptor mediated response in the rat medial prefrontal cortical pyramidal cells by the 5-HT3 receptor agonist SR 57227A and 5-HT: intracellular studiesX Liang, V L Arvanov, R Y WangAcademic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|December 31, 1997
Pediatric gamma hydroxybutyrate intoxicationS Suner, C S Szlatenyi, R Y WangNucleic Acids Research|February 25, 1986
A human DNA-binding protein is methylation-specific and sequence-specificR Y Wang, X Y Zhang, M EhrlichBrain Research|July 16, 1993
Further characterization of 5-HT- and 5-HT3 receptor agonists'-stimulated phosphoinositol phosphates accumulationE Edwards, C R Ashby, R Y WangBrain Research|May 27, 1991
The CCK-A receptor antagonist devazepide but not the CCK-B receptor antagonist L-365,260 reverses the effects of chronic clozapine and haloperidol on midbrain dopamine neuronsY Minabe, C R Ashby, R Y WangNeuroreport|December 1, 1992
Biochemical characterization of phosphoinositide hydrolysis stimulated by 5-HT3 receptor agonistsE Edwards, C R Ashby, R Y WangNeuropharmacology|March 21, 2003
Olanzapine and clozapine but not haloperidol reverse subchronic phencyclidine-induced functional hyperactivity of N-methyl-D-aspartate receptors in pyramidal cells of the rat medial prefrontal cortexI Ninan, K E Jardemark, R Y WangBrain Research|July 18, 1994
The 5-HT3 receptor agonist 2-methyl-5-HT reduces postsynaptic potentials in rat CA1 pyramidal neurons of the hippocampus in vitroM L Zeise, K Batsche, R Y WangThe Journal of Pharmacology and Experimental Therapeutics|April 1, 1986
Cholecystokinin octapeptides alter the release of endogenous dopamine from the rat nucleus accumbens in vitroM Voigt, R Y Wang, T C WestfallZhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases|December 9, 2025
[Phage therapy for respiratory infections: from experimental evidence to clinical challenge]R Y Wang, J Wang, F W JiaoPageof 27